Search Results

Refine Search

News & Features

Biotechnology

An update on patenting in Ukraine, Russia and Eurasia

Erik Viik of Papula-Nevinpat looks at the dynamics that international applicants need to be aware of to secure and manage their patent rights across the region. 2 September 2025

Americas

The right formula: Minimising the cost of chemical and pharma patents

From setting a clear overall strategy to drafting high-quality claims, Christopher Wheeler and Gerald Murphy of Birch, Stewart, Kolasch & Birch explain how to reduce patent prosecution expenditure and obtain better IP protection. 26 August 2025

Asia

Overcoming refusal of TMs containing ingredient names in China

Hui Zhuang of CCPIT Patent and Trademark Law Office discusses several strategies to increase the chance of pharmaceutical or food trademarks that include ingredients being registered. 21 August 2025

Africa

Explainer: ARIPO’s role in Plant Variety Protection

Africa’s agricultural future is imperative to life and prosperity in the region—and the Arusha Protocol gives breeders the protection they need, explains the African Regional Intellectual Property Organization. 15 July 2025

Africa

Commercialising genomic tech in Nigeria

Genomic innovations involve vast amounts of research, making patents, copyrights, and trade secrets vital, explains Olusola Tunmise-Ajani of Inventa International. 29 April 2025

Asia

How post-filing data rescued Novo Nordisk’s Ozempic patent in China

The Beijing IP court’s decision to revive a key semaglutide patent based on experimental data has far-reaching legal and economic implications, says Jennifer Che of Eagle IP 15 October 2024

Asia

How to navigate patent term adjustment in China

Recent updates to China’s patent law provide guidelines on PTA calculations, definitions of delays and challenging decisions, say Audrey Cheung, Yolanda Wang and Jennifer Che of Eagle IP. 8 October 2024

Americas

‘Masking only works for so long’: Working with ADHD

Being a lawyer with ADHD is far from easy due to widespread misconceptions about the condition but there are ways to offer support, says Lisa Mueller of Casimir Jones. 1 August 2024

Big Pharma

Amgen v Sanofi/Regeneron in Japan: Function, sequence, mechanism

Amgen patents declared valid in Germany and Japan have also been deemed invalid by the European Patent Office, US Supreme Court, and in a separate Japan decision: but why? Takanori Abe of Abe & Partners examines the details. 19 March 2024

Careers

Weil continues IP expansion as another litigator jumps from rival firm

The ‘distinguished litigator’ rejoins six former colleagues at the new firm, bringing expertise in high-stakes disputes representing global tech and life sciences clients. 7 November 2025